Efficacy & Toxicity of CAR-T Trials and The Echelon-1 Trial Brentuximab Vedotin + AVD or ABVD - 100459

Spotlight
Video

Efficacy & Toxicity of CAR-T Trials and The Echelon-1 Trial Brentuximab Vedotin + AVD or ABVD

moasc has 332 videos Subscribe Here

Loading........
Description: Elizabeth Brém, MD - HS Clinical Assistant Professor Chao Comprehensive Cancer Center discusses Efficacy & Toxicity of CAR-T Trials and The Echelon-1 Trial Brentuximab Vedotin + AVD or ABVD at MOASC’s Spotlight On Hematology in Huntington Beach 2018.
Shared By : moasc
Posted on : 02/06/18
Added : 8 months ago
Category : Lymphoma



Recommended

Nothing found.